-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 IZttyGegEqMJnKxJKZIFekhxl1FCdl7xL6xj5Jrx8MehN+Hj/lIdLMuDCTa+2mUa
 Kk1y1hbw+T0th5yQVAO0aA==

<SEC-DOCUMENT>0001078784-05-000005.txt : 20050613
<SEC-HEADER>0001078784-05-000005.hdr.sgml : 20050611
<ACCEPTANCE-DATETIME>20050613112904
ACCESSION NUMBER:		0001078784-05-000005
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20050609
FILED AS OF DATE:		20050613
DATE AS OF CHANGE:		20050613

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOJECT MEDICAL TECHNOLOGIES INC
		CENTRAL INDEX KEY:			0000810084
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				931099680
		STATE OF INCORPORATION:			OR
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		211 SOMERVILLE ROAD
		STREET 2:		ROUTE 202 NORTH
		CITY:			BEDMINSTER
		STATE:			NJ
		ZIP:			07921
		BUSINESS PHONE:		9084702800

	MAIL ADDRESS:	
		STREET 1:		211 SOMERVILLE ROAD
		STREET 2:		ROUTE 202 NORTH
		CITY:			BEDMINSTER
		STATE:			NJ
		ZIP:			07921

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOJECT MEDICAL SYSTEMS LTD
		DATE OF NAME CHANGE:	19920703

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			CHASE RANDAL D
		CENTRAL INDEX KEY:			0001078784

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-15360
		FILM NUMBER:		05891577

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		4103097100

	MAIL ADDRESS:	
		STREET 1:		C/O NORTH AMERICAN VACCINE INC
		STREET 2:		10150 OLD COLUMBIA ROAD
		CITY:			COLUMBIA
		STATE:			MD
		ZIP:			21046
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>cha108.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2005-06-09</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0000810084</issuerCik>
        <issuerName>BIOJECT MEDICAL TECHNOLOGIES INC</issuerName>
        <issuerTradingSymbol>BJCT</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001078784</rptOwnerCik>
            <rptOwnerName>CHASE RANDAL D</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>211 SOMERVILLE ROAD</rptOwnerStreet1>
            <rptOwnerStreet2>ROUTE 202 N</rptOwnerStreet2>
            <rptOwnerCity>BEDMINSTER</rptOwnerCity>
            <rptOwnerState>NJ</rptOwnerState>
            <rptOwnerZipCode>07921</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Restricted Stock Unit</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>1.14</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2005-06-09</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>3000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>1.14</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>3000.00</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>3000.00</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value></value>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">50% Vest on 12/9/05, 50% Vest on 6/9/06</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>By: John Gandolfo, Attorney-in-fact</signatureName>
        <signatureDate>2005-06-13</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----